Patents by Inventor Colin R. Parrish

Colin R. Parrish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated canine parvovirus vaccine
    Patent number: 5885585
    Abstract: The invention is directed to attenuated canine parvovirus (CPV) strains which may be used as a veterinary vaccine against CPV disease. The invention is further directed to a virus stock generated from a genomic DNA clone of the attenuated CPV strain which is used as a veterinary vaccine and is able to confer protective immunity to dogs against challenge with virulent CPV. Methods are given for the production of an attenuated CPV virus from a cloned CPV genome which may be used as a veterinary vaccine.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: March 23, 1999
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Colin R. Parrish, Leland E. Carmichael, Allen Gruenberg
  • Attenuated canine parvovirus vaccine
    Patent number: 5814510
    Abstract: The invention is directed to a novel attenuated canine parvovirus (CPV) strain which may be used as a veterinary vaccine against CPV disease. The invention is further directed to a virus stock generated from a genomic DNA clone of the attenuated CPV strain which is used as a veterinary vaccine and is able to confer protective immunity to dogs against challenge with virulent CPV. Methods are given for the production of an attenuated CPV virus from a cloned CPV genome which may be used as a veterinary vaccine.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: September 29, 1998
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Colin R. Parrish, Allen Gruenberg, Leland E. Carmichael
  • Subunit canine parvovirus vaccine
    Patent number: 4971793
    Abstract: A recombinant subunit vaccine for protecting dogs against infection caused by canine parvovirus comprising VP-2 protein produced during replication of a recombinant baculovirus in insect tissue culture cells or insects which are a permissive host for the replication of selected baculoviruses.
    Type: Grant
    Filed: May 9, 1988
    Date of Patent: November 20, 1990
    Assignees: Boyce Thompson Institute for Plant Research, Inc., Cornell Research Foundation, Inc.
    Inventors: Harry A. Wood, Colin R. Parrish